Author

Pantelis Karageorgis

Observed names: P Karageorgis, P. Karageorgis

Observed institutions: Papageorgiou General Hospital, St Savas Hospital, Metaxa Hospital

OpenAlex ID: A5035840252

Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases

2002 · D. Antonadou, M. Paraskevaidis, et al. · Journal of Clinical Oncology · 332

Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme

2005 · Helen Athanassiou, Maria Synodinou, et al. · Journal of Clinical Oncology · 272

Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

2001 · Dosia Antonadou, Nikos Coliarakis, et al. · International Journal of Radiation Oncology*Biology*Physics · 201

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial

2003 · Helen Athanassiou, Dosia Antonadou, et al. · International Journal of Radiation Oncology*Biology*Physics · 118

Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study

2002 · D Antonadou, N Coliarakis, et al. · International Journal of Radiation Oncology*Biology*Physics · 50

18 Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer

1999 · D. Antonadou, N. Coliarakis, et al. · International Journal of Radiation Oncology*Biology*Physics · 19

PDF

O-67 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus to radiotherapy alone

2003 · Dosia Antonadou, Nikolaos Coliarakis, et al. · Lung Cancer · 13

Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group

2004 · D. Antonadou, H. Athanassiou, et al. · International Journal of Radiation Oncology*Biology*Physics · 9

Radiation dermatitis: implicated factors, clinical aspects, possible prevention, and medical care.

2007 · A Markouizou, N Koliarakis, et al. · PubMed · 7

A Multicenter, Open Study Evaluating the Impact of Darbepoetin Alfa on Anaemia and Quality of Life, in Cancer Patients Undergoing Radiotherapy

2005 · D. Antonadou, P. Varveris, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

PDF

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

2004 · H. Athanassiou, M. Synodinou, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

PDF

311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study

2003 · H. Athanassiou, M. Synodinou, et al. · European Journal of Cancer Supplements · 2

777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone

2003 · D. Antonadou, N. Coliarakis, et al. · European Journal of Cancer Supplements · 2

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial

2001 · E. Athanassiou, D. Antonadou, et al. · European Journal of Cancer · 2

Contribution of the hyperdynamic radiotherapy in the treatment of the nasopharynx tumors.

1982 · P Karageorgis, E Emmanuil, et al. · PubMed · 2

Phase I study of postoperative radiotherapy with concomitant weekly irinotecan, 5- fluorouracil and folinic acid in locally advanced rectal cancer.

2004 · N Ziras, P Tsoutsou, et al. · PubMed · 1

1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer

2003 · D. Antonadou, H. Athanassiou, et al. · European Journal of Cancer Supplements · 1

Effect of amifostine on toxicities associated with induction chemotherapy and radiotherapy for head and neck and lung cancer

1999 · D. Antonadou, N. Bolanos, et al. · European Journal of Cancer · 1

Darbepoetin alfa improves quality of life in cancer patients undergoing radiation, final results of a multicenter, open study

2006 · D. Antonadou, P. Varveris, et al. · Journal of Clinical Oncology

180 Combined radiotherapy with irinotecan (CPT-11), interferon a2b (IFNa2b) and amifostine in patients with locally advanced cervical carcinoma (LACC)

2003 · G. Sarris, D. Bafaloukos, et al. · European Journal of Cancer Supplements

103 Comparative study between intravenous and subcutaneous amifostine administered for the prevention of radiation induced toxicities in patients with head and neck cancer

2003 · M. Synodinou-Menegaki, D. Antonadou, et al. · European Journal of Cancer Supplements

646Comparative study between hemobody irradiation and strontium 89 for the palliation of multiple painful bone metastases from prostatic cancer

1996 · D. Antonadou, D. Apostolou, et al. · Radiotherapy and Oncology

Hyperfractionated accelerated radiotherapy combined with alpha-2 interferon in the treatment of non small cell lung cancer

1994 · M. Paraskevaides, N. Koliarakis, et al. · European Journal of Cancer

Multiform glioblastoma combined therapy by radiation and A-interferon

1993 · N. Coliarakis, M. Paraskevaides, et al. · European Journal of Cancer

Works count: 24

Citation count: 1,037

H-index: 8

I10-index: 7